Onderneming eFFECTOR Therapeutics, Inc.
Aandelen
EFTR
US28202V2079
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,89 USD | +4,42% | +11,18% | -83,83% |
Vakgebied
Aantal werknemers: 14
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 01-12-20 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 08-08-22 |
Mark Densel
PRN | Corporate Officer/Principal | - | 01-11-18 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 26-09-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Director/Board Member | 54 | 25-08-21 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 11-09-23 |
Brian Gallagher
CHM | Chairman | 54 | 01-01-20 |
Barbara Klencke
BRD | Director/Board Member | 66 | 01-11-21 |
Elizabeth Bhatt
BRD | Director/Board Member | 56 | 25-08-21 |
Director/Board Member | 51 | 15-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 699 309 | 3 553 586 ( 96,06 %) | 12 000 ( 0,3244 %) | 96,06 % |
Bedrijfsgegevens
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-83,83% | 6,97 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers EFTR
- Onderneming eFFECTOR Therapeutics, Inc.